Skip to main content
Top
Published in: Journal of Translational Medicine 1/2017

Open Access 01-12-2017 | Research

Proteomic analysis of sputum reveals novel biomarkers for various presentations of asthma

Authors: Chao Cao, Wen Li, Wen Hua, Fugui Yan, Hao Zhang, Huaqiong Huang, Yinghua Ying, Na Li, Fen Lan, Shaobin Wang, Xiao Chen, Jing Li, Jinkai Liu, Tianwen Lai, Zhengqiang Bao, Yuan Cao, Yun Zhao, Gang Huang, Lili Huang, Yaqing Huang, Ping Wu, Chao Peng, Zhihua Chen, Kian Fan Chung, Nanshan Zhong, Songmin Ying, Huahao Shen

Published in: Journal of Translational Medicine | Issue 1/2017

Login to get access

Abstract

Background

It is now recognized that asthma can present in different forms. Typically, asthma present with symptoms of wheeze, breathlessness and cough. Atypical forms of asthma such as cough variant asthma (CVA) or chest tightness variant asthma (CTVA) do not wheeze. We hypothesize that these different forms of asthma may have distinctive cellular and molecular features.

Methods

30 patients with typical or classical asthma (CA), 27 patients with CVA, 30 patients with CTVA, and 30 healthy control adults were enrolled in this prospective study. We measured serum IgE, lung function, sputum eosinophils, nitric oxide in exhaled breath (FeNO). We performed proteomic analysis of induced-sputum supernatants by mass spectrometry.

Results

There were no significant differences in atopy and FEV1 among patients with CA, CVA, and CTVA. Serum IgE, sputum eosinophil percentages, FeNO, anxiety and depression scores were significantly increased in the three presentations of asthmatic patients as compared with healthy controls but there was no difference between the asthmatic groups. Comprehensive mass spectrometric analysis revealed more than a thousand proteins in the sputum from patients with CA, CVA, and CTVA, among which 23 secreted proteins were higher in patients than that in controls.

Conclusions

Patients with CA, CVA, or CTVA share common clinical characteristics of eosinophilic airway inflammation. And more importantly, their sputum samples were composed with common factors with minor distinctions. These findings support the concept that these three different presentations of asthma have similar pathogenetic mechanism in terms of an enhanced Th2 associated with eosinophilia. In addition, this study identified a pool of novel biomarkers for diagnosis of asthma and to label its subtypes.
Trial registration http://​www.​chictr.​org.​cn (ChiCTR-OOC-15006221)
Appendix
Available only for authorised users
Literature
1.
go back to reference Morosco G, Kiley J: National asthma education and prevention program—expert panel report 3: guidelines for the diagnosis and management of asthma summary report 2007—Preface. J Allergy Clin Immunol. 2007; 120(5). Morosco G, Kiley J: National asthma education and prevention program—expert panel report 3: guidelines for the diagnosis and management of asthma summary report 2007—Preface. J Allergy Clin Immunol. 2007; 120(5).
2.
go back to reference Mortagy AK, Howell JB, Waters WE. Respiratory symptoms and bronchial reactivity: identification of a syndrome and its relation to asthma. Br Med J (Clin Res ed). 1986;293(6546):525–9.CrossRef Mortagy AK, Howell JB, Waters WE. Respiratory symptoms and bronchial reactivity: identification of a syndrome and its relation to asthma. Br Med J (Clin Res ed). 1986;293(6546):525–9.CrossRef
3.
go back to reference Farr RS, Kopetzky MT, Spector SL, Hurewitz DS. Asthma without wheezing. Chest. 1973;63(Suppl):64S–8S.CrossRef Farr RS, Kopetzky MT, Spector SL, Hurewitz DS. Asthma without wheezing. Chest. 1973;63(Suppl):64S–8S.CrossRef
4.
go back to reference Myers JR, Corrao WM, Braman SS. Clinical applicability of a methacholine inhalational challenge. JAMA. 1981;246(3):225–9.CrossRefPubMed Myers JR, Corrao WM, Braman SS. Clinical applicability of a methacholine inhalational challenge. JAMA. 1981;246(3):225–9.CrossRefPubMed
5.
go back to reference Anderson GP. Endotyping asthma: new insights into key pathogenic mechanisms in a complex, heterogeneous disease. Lancet. 2008;372(9643):1107–19.CrossRefPubMed Anderson GP. Endotyping asthma: new insights into key pathogenic mechanisms in a complex, heterogeneous disease. Lancet. 2008;372(9643):1107–19.CrossRefPubMed
6.
go back to reference Fajt ML, Wenzel SE. Asthma phenotypes and the use of biologic medications in asthma and allergic disease: the next steps toward personalized care. J Allergy Clin Immunol. 2015;135(2):299–310 (quiz 311).CrossRefPubMed Fajt ML, Wenzel SE. Asthma phenotypes and the use of biologic medications in asthma and allergic disease: the next steps toward personalized care. J Allergy Clin Immunol. 2015;135(2):299–310 (quiz 311).CrossRefPubMed
7.
8.
go back to reference Corrao WM, Braman SS, Irwin RS. Chronic cough as the sole presenting manifestation of bronchial asthma. N Engl J Med. 1979;300(12):633–7.CrossRefPubMed Corrao WM, Braman SS, Irwin RS. Chronic cough as the sole presenting manifestation of bronchial asthma. N Engl J Med. 1979;300(12):633–7.CrossRefPubMed
9.
go back to reference Shen H, Hua W, Wang P, Li W. A new phenotype of asthma: chest tightness as the sole presenting manifestation. Ann Allergy Asthma Immunol Off Publ Am Coll Allergy Asthma Immunol. 2013;111(3):226–7.CrossRef Shen H, Hua W, Wang P, Li W. A new phenotype of asthma: chest tightness as the sole presenting manifestation. Ann Allergy Asthma Immunol Off Publ Am Coll Allergy Asthma Immunol. 2013;111(3):226–7.CrossRef
11.
go back to reference Irwin RS. Chest tightness variant asthma (CTVA): reconfirmed and not generally appreciated. J Thorac Dis. 2014;6(5):405–6.PubMedPubMedCentral Irwin RS. Chest tightness variant asthma (CTVA): reconfirmed and not generally appreciated. J Thorac Dis. 2014;6(5):405–6.PubMedPubMedCentral
12.
go back to reference ATS/ERS recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide, 2005. Am J Respir Crit Care Med. 2005;171(8):912–30. ATS/ERS recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide, 2005. Am J Respir Crit Care Med. 2005;171(8):912–30.
13.
go back to reference Wang Q, Ji J, Xie Y, Guan W, Zhang Y, Wang Z, Wu K, Zhong N. Lower airway inflammation and hyperresponsiveness in non-asthmatic patients with non-allergic rhinitis. J Thorac Dis. 2015;7(10):1756–64.PubMedPubMedCentral Wang Q, Ji J, Xie Y, Guan W, Zhang Y, Wang Z, Wu K, Zhong N. Lower airway inflammation and hyperresponsiveness in non-asthmatic patients with non-allergic rhinitis. J Thorac Dis. 2015;7(10):1756–64.PubMedPubMedCentral
14.
go back to reference Xia J, Mandal R, Sinelnikov IV, Broadhurst D, Wishart DS. MetaboAnalyst 2.0—a comprehensive server for metabolomic data analysis. Nucleic Acids Res. 2012;40(Web Server issue):W127–33.CrossRefPubMedPubMedCentral Xia J, Mandal R, Sinelnikov IV, Broadhurst D, Wishart DS. MetaboAnalyst 2.0—a comprehensive server for metabolomic data analysis. Nucleic Acids Res. 2012;40(Web Server issue):W127–33.CrossRefPubMedPubMedCentral
15.
go back to reference Trojan TD, Khan DA, Defina LF, Akpotaire O, Goodwin RD, Brown ES. Asthma and depression: the Cooper Center Longitudinal Study. Ann Allergy Asthma Immunol Off Publ Am Coll Allergy Asthma Immunol. 2014;112(5):432–6.CrossRef Trojan TD, Khan DA, Defina LF, Akpotaire O, Goodwin RD, Brown ES. Asthma and depression: the Cooper Center Longitudinal Study. Ann Allergy Asthma Immunol Off Publ Am Coll Allergy Asthma Immunol. 2014;112(5):432–6.CrossRef
16.
go back to reference Liu S, Wu R, Li L, Liu L, Li G, Zhang X, Guo Y, Wang Y, Zhang H, Li G, et al. The prevalence of anxiety and depression in Chinese asthma patients. PLoS ONE. 2014;9(7):e103014.CrossRefPubMedPubMedCentral Liu S, Wu R, Li L, Liu L, Li G, Zhang X, Guo Y, Wang Y, Zhang H, Li G, et al. The prevalence of anxiety and depression in Chinese asthma patients. PLoS ONE. 2014;9(7):e103014.CrossRefPubMedPubMedCentral
17.
go back to reference Han YY, Forno E, Marsland AL, Miller GE, Celedon JC. Depression, asthma, and bronchodilator response in a nationwide study of US adults. J Allergy Clin Immunol Prac. 2016;4(1):68–73.CrossRef Han YY, Forno E, Marsland AL, Miller GE, Celedon JC. Depression, asthma, and bronchodilator response in a nationwide study of US adults. J Allergy Clin Immunol Prac. 2016;4(1):68–73.CrossRef
18.
go back to reference Bousquet J, Chanez P, Vignola AM, Lacoste JY, Michel FB. Eosinophil inflammation in asthma. Am J Respir Crit Care Med. 1994;150(5 Pt 2):S33–8.CrossRefPubMed Bousquet J, Chanez P, Vignola AM, Lacoste JY, Michel FB. Eosinophil inflammation in asthma. Am J Respir Crit Care Med. 1994;150(5 Pt 2):S33–8.CrossRefPubMed
19.
go back to reference Yoo Y, Koh YY, Kang H, Yu J, Nah KM, Kim CK. Sputum eosinophil counts and eosinophil cationic protein levels in cough-variant asthma and in classic asthma, and their relationships to airway hypersensitivity or maximal airway response to methacholine. Allergy. 2004;59(10):1055–62.CrossRefPubMed Yoo Y, Koh YY, Kang H, Yu J, Nah KM, Kim CK. Sputum eosinophil counts and eosinophil cationic protein levels in cough-variant asthma and in classic asthma, and their relationships to airway hypersensitivity or maximal airway response to methacholine. Allergy. 2004;59(10):1055–62.CrossRefPubMed
20.
go back to reference Newby C, Agbetile J, Hargadon B, Monteiro W, Green R, Pavord I, Brightling C, Siddiqui S. Lung function decline and variable airway inflammatory pattern: longitudinal analysis of severe asthma. J Allergy Clin Immunol. 2014;134(2):287–94.CrossRefPubMed Newby C, Agbetile J, Hargadon B, Monteiro W, Green R, Pavord I, Brightling C, Siddiqui S. Lung function decline and variable airway inflammatory pattern: longitudinal analysis of severe asthma. J Allergy Clin Immunol. 2014;134(2):287–94.CrossRefPubMed
22.
go back to reference Uhm TG, Kim BS, Chung IY. Eosinophil development, regulation of eosinophil-specific genes, and role of eosinophils in the pathogenesis of asthma. Allergy Asthma Immunol Res. 2012;4(2):68–79.CrossRefPubMed Uhm TG, Kim BS, Chung IY. Eosinophil development, regulation of eosinophil-specific genes, and role of eosinophils in the pathogenesis of asthma. Allergy Asthma Immunol Res. 2012;4(2):68–79.CrossRefPubMed
23.
go back to reference Lee BJ, Jeung YJ, Lee JY, Choi DC. Increased S-nitrosothiol levels in nonasthmatic eosinophilic bronchitis compared with cough variant asthma. Int Arch Allergy Immunol. 2011;156(1):99–103.CrossRefPubMed Lee BJ, Jeung YJ, Lee JY, Choi DC. Increased S-nitrosothiol levels in nonasthmatic eosinophilic bronchitis compared with cough variant asthma. Int Arch Allergy Immunol. 2011;156(1):99–103.CrossRefPubMed
24.
go back to reference De Diego A, Martinez E, Perpina M, Nieto L, Compte L, Macian V, Senent L. Airway inflammation and cough sensitivity in cough-variant asthma. Allergy. 2005;60(11):1407–11.CrossRefPubMed De Diego A, Martinez E, Perpina M, Nieto L, Compte L, Macian V, Senent L. Airway inflammation and cough sensitivity in cough-variant asthma. Allergy. 2005;60(11):1407–11.CrossRefPubMed
25.
go back to reference Niimi A, Amitani R, Suzuki K, Tanaka E, Murayama T, Kuze F. Eosinophilic inflammation in cough variant asthma. Eur Respir J. 1998;11(5):1064–9.CrossRefPubMed Niimi A, Amitani R, Suzuki K, Tanaka E, Murayama T, Kuze F. Eosinophilic inflammation in cough variant asthma. Eur Respir J. 1998;11(5):1064–9.CrossRefPubMed
26.
go back to reference Munoz X, Bustamante V, Lopez-Campos JL, Cruz MJ, Barreiro E. Usefulness of noninvasive methods for the study of bronchial inflammation in the control of patients with asthma. Int Arch Allergy Immunol. 2015;166(1):1–12.CrossRefPubMed Munoz X, Bustamante V, Lopez-Campos JL, Cruz MJ, Barreiro E. Usefulness of noninvasive methods for the study of bronchial inflammation in the control of patients with asthma. Int Arch Allergy Immunol. 2015;166(1):1–12.CrossRefPubMed
27.
go back to reference Korevaar DA, Westerhof GA, Wang J, Cohen JF, Spijker R, Sterk PJ, Bel EH, Bossuyt PM. Diagnostic accuracy of minimally invasive markers for detection of airway eosinophilia in asthma: a systematic review and meta-analysis. Lancet Respir Med. 2015;3(4):290–300.CrossRefPubMed Korevaar DA, Westerhof GA, Wang J, Cohen JF, Spijker R, Sterk PJ, Bel EH, Bossuyt PM. Diagnostic accuracy of minimally invasive markers for detection of airway eosinophilia in asthma: a systematic review and meta-analysis. Lancet Respir Med. 2015;3(4):290–300.CrossRefPubMed
28.
29.
go back to reference Lloyd CM, Saglani S. T cells in asthma: influences of genetics, environment, and T-cell plasticity. J Allergy Clin Immunol. 2013;131(5):1267–74 (quiz 1275).CrossRefPubMed Lloyd CM, Saglani S. T cells in asthma: influences of genetics, environment, and T-cell plasticity. J Allergy Clin Immunol. 2013;131(5):1267–74 (quiz 1275).CrossRefPubMed
30.
go back to reference Tamm M, Richards DH, Beghe B, Fabbri L. Inhaled corticosteroid and long-acting beta2-agonist pharmacological profiles: effective asthma therapy in practice. Respir Med. 2012;106(Suppl 1):S9–19.CrossRefPubMed Tamm M, Richards DH, Beghe B, Fabbri L. Inhaled corticosteroid and long-acting beta2-agonist pharmacological profiles: effective asthma therapy in practice. Respir Med. 2012;106(Suppl 1):S9–19.CrossRefPubMed
Metadata
Title
Proteomic analysis of sputum reveals novel biomarkers for various presentations of asthma
Authors
Chao Cao
Wen Li
Wen Hua
Fugui Yan
Hao Zhang
Huaqiong Huang
Yinghua Ying
Na Li
Fen Lan
Shaobin Wang
Xiao Chen
Jing Li
Jinkai Liu
Tianwen Lai
Zhengqiang Bao
Yuan Cao
Yun Zhao
Gang Huang
Lili Huang
Yaqing Huang
Ping Wu
Chao Peng
Zhihua Chen
Kian Fan Chung
Nanshan Zhong
Songmin Ying
Huahao Shen
Publication date
01-12-2017
Publisher
BioMed Central
Published in
Journal of Translational Medicine / Issue 1/2017
Electronic ISSN: 1479-5876
DOI
https://doi.org/10.1186/s12967-017-1264-y

Other articles of this Issue 1/2017

Journal of Translational Medicine 1/2017 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine